International Stem Cell ISCO
OTC ISCO
$0.30 -0.01 (-3.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

International Stem Cell (ISCO) Return on Capital Employed [ROCE] (2011 - 2025)

Updated

International Stem Cell (ISCO) reported Return on Capital Employed [ROCE] of -56.63% for Q4 2025, down 42.71 percentage points from -13.92% a year earlier and down 69.40 percentage points from the prior quarter.

Analysis

International Stem Cell (ISCO) Return on Capital Employed [ROCE] (2011 - 2025) Analysis & Trends

For FY2025, International Stem Cell posted Return on Capital Employed [ROCE] of -64.03%, down 52.57 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -0.99 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -11.46% in FY2024 (+142.55 pp), -154.01% in FY2023 (-108.88 pp), -45.13% in FY2022 (+185.62 pp) and -230.75% in FY2021 (-167.72 pp).
  • The Q4 2025 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in four of the last eight quarters, with an average year-over-year change of +14.74 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2023 (a gain of 271.08 percentage points); the low point was Q4 2021 (a drop of 222.90 percentage points).
  • Per Business Quant data, the three quarters before Q4 2025 came in at 12.77% (Q3 2025), -13.46% (Q2 2025) and -36.14% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 International Stem Cell 2.40 Mn -1.57 Mn 1.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -56.63%
Sep 30, 2025 12.77%
Jun 30, 2025 -13.46%
Mar 31, 2025 -36.14%
Dec 31, 2024 -13.92%
Sep 30, 2024 -81.17%
Jun 30, 2024 -120.22%
Mar 31, 2024 -203.87%
Dec 31, 2023 -97.00%
Sep 30, 2023 -17.26%
Jun 30, 2023 -46.49%
Mar 31, 2023 -50.61%
Dec 31, 2022 -40.35%
Sep 30, 2022 -92.05%
Jun 30, 2022 -116.42%
Mar 31, 2022 -321.70%
Dec 31, 2021 -291.86%
Sep 30, 2021 -251.78%
Jun 30, 2021 -180.92%
Mar 31, 2021 -314.38%
API Access

International Stem Cell Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEY